CSRT.L Regulatory News (CSRT)

News Release

30 August 2012

Consort Medical plc

Interim Management Statement

Consort Medical plc (LSE: CSRT), today issues its Interim Management Statement for the period from 1 May 2012 to date.

The Group is trading in line with expectations and the Board remains confident about the outlook for the full year.

Bespak has continued to make good progress with its broad development portfolio, with a number of launches scheduled over the next twelve months.

At King Systems, the rollout of the King Vision video laryngoscope continues to make excellent progress, with volumes and revenues increasing, both in the US and internationally.

As previously reported Chris Banks and Jim Dick retire from the Board today and we thank them for their significant contribution to the business over the past number of years.

There has been no significant change in the Group's consolidated financial position since the publication of the preliminary results, on 14 June 2012, for the year ended 30 April 2012.

-Ends-

For enquiries, please contact:

Consort Medical plc is an international medical devices company, focused on developing and manufacturing disposable medical devices for drug delivery and anaesthesia.

The Group is comprised of two businesses:

Bespak is a global market leader in the manufacture of drug delivery devices for pharmaceutical partner companies, including products across the respiratory, injectables and Point of Care markets.

King Systems manufactures and markets airway management products, used primarily by anaesthetists and emergency room practitioners.

The Group has facilities in King's Lynn, Cambridge, Nelson and Hemel Hempstead in the UK, and Indianapolis, Indiana and Kent, Ohio in the US.

Consort Medical is a public company quoted on the full list of the London Stock Exchange (LSE: CSRT).